Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors

Overview of attention for article published in Frontiers in immunology, October 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 180 Dimensions

Readers on

mendeley: 320 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 5 X users, with an upper bound of 37,935 followers.

@BLLPHD @AGCT_team @PennMedicine @NatureCancer You finally got the message about the binders, eh?

25 Mar 2022

Reply Repost Favourite

https://t.co/FZH5r5Mslh https://t.co/2Hl7VZwLiU

19 Oct 2021

Reply Repost Favourite

Xenaki et al. 2017: https://t.co/FZH5r5Mslh

19 Oct 2021

Reply Repost Favourite

Let’s just remember that nanobodies have been around for a while. This acquisitions has to do with CAR T binders, but Amgen can’t stop other groups from using VHH binders as they are obvious, not novel, anticipated by prior art, etc. https://t.co/FZH5r5M

19 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.